Evidence map›Paper›PMID 39531117›Full record

ArticleAIDS and behavior2025

A Qualitative Assessment of South Africa's Central Chronic Medication Dispensing and Distribution Program for Differentiated Antiretroviral Therapy Delivery in Umlazi Township, South Africa: Client Perspectives after 12 Months of Participation.

Alexandra Mendoza-Graf, Laura M Bogart, Zinhle Shazi, Anele Khumalo, Nabeel Qureshi, Kashfia Rahman, Sabina Govere, Dani Zionts, Mpilonhle Nzuza, Ingrid V Bassett

Abstract read
In one paragraph

Article in AIDS and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Alexandra Mendoza-Graf *RAND Corporation, Santa Monica, CA, USA.
Laura M Bogart *RAND Corporation, Santa Monica, CA, USA.
Zinhle ShaziAIDS Healthcare Foundation, Durban, South Africa.
Anele KhumaloAIDS Healthcare Foundation, Durban, South Africa.
Nabeel QureshiRAND Corporation, Santa Monica, CA, USA.
Kashfia RahmanMedical Practice Evaluation Center, Massachusetts General Hospital, 100 Cambridge Street, 16th Floor, Boston, MA, 02114, USA.
Sabina GovereAIDS Healthcare Foundation, Durban, South Africa.
Dani ZiontsMedical Practice Evaluation Center, Massachusetts General Hospital, 100 Cambridge Street, 16th Floor, Boston, MA, 02114, USA.
Mpilonhle NzuzaAIDS Healthcare Foundation, Durban, South Africa.
Ingrid V BassettMedical Practice Evaluation Center, Massachusetts General Hospital, 100 Cambridge Street, 16th Floor, Boston, MA, 02114, USA. ibassett@mgh.harvard.edu.ORCID http://orcid.org/0000-0001-6920-6080

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Sung-Jae Lee · 1997 to 2026
$53.5M
South Africa's new Central Chronic Medicine Dispensing and Distribution program: assessing the clinic, patient, and community impactR01MH114997 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI BASSETT, INGRID VALERIE · 2018 to 2022
$3.4M
Foundation for the National Institutes of Health MH114997Graham Family Graham FamilyMassachusetts General Hospital Massachusetts General HospitalNIMH NIH HHS P30 MH058107NIMH NIH HHS R01 MH114997
6 · The paper itself

Abstract

South Africa's Central Chronic Medicine Dispensing and Distribution (CCMDD) program provides community-based medication delivery for clinically stable people with HIV (PWH) on antiretroviral therapy (ART). To evaluate CCMDD implementation, we conducted semi-structured interviews with 60 PWH enrolled in CCMDD for at least 12 months. In a directed content analysis based on the Practical, Robust Implementation and Sustainability Model (PRISM) implementation science framework, key themes were compared with qualitative data collected from PWH enrolling in CCMDD at an earlier time-point. Results indicated consistently positive views of CCMDD, primarily attributed to convenient and smooth medication pick-up. At the later (vs. earlier) time-point, participants discussed less clinic crowding, mentioned few medication errors, and noted improved communication around refills. Community HIV stigma was a persistent challenge, as was nurses' judgmental communication style. To ensure CCMDD's success, continued focus is needed on decreasing HIV stigma beyond the clinic context and improving provider-patient relationships.

Indexed as

Anti-HIV AgentsAnti-Retroviral AgentsCommunity Health ServicesHIV InfectionsAdultFemaleHumansInterviews as TopicMaleMedication AdherenceMiddle AgedProgram EvaluationQualitative ResearchSocial StigmaSouth AfricaAnti-HIV AgentsAnti-Retroviral AgentsAIDSAntiretroviral therapyCentral Chronic Medicine Dispensing and DistributionHIVImplementation science

Identifiers

PMID39531117
PMCPMC11813671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.